316 related articles for article (PubMed ID: 26261566)
21. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.
Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793
[TBL] [Abstract][Full Text] [Related]
22. The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy.
Zhang C; Nie J; Feng L; Luo W; Yao J; Wang F; Wang H
Discov Med; 2016 Apr; 21(116):227-37. PubMed ID: 27232509
[TBL] [Abstract][Full Text] [Related]
23. Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension.
Silva KC; Pinto CC; Biswas SK; de Faria JB; de Faria JM
Curr Eye Res; 2007 Jun; 32(6):533-41. PubMed ID: 17612969
[TBL] [Abstract][Full Text] [Related]
24. LncRNA HOTTIP improves diabetic retinopathy by regulating the p38-MAPK pathway.
Sun Y; Liu YX
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2941-2948. PubMed ID: 29863235
[TBL] [Abstract][Full Text] [Related]
25. Diabetes: a potential enhancer of retinal injury in rat retinas.
Oshitari T; Roy S
Neurosci Lett; 2005 Dec; 390(1):25-30. PubMed ID: 16154273
[TBL] [Abstract][Full Text] [Related]
26. Nuclear PKR in retinal neurons in the early stage of diabetic retinopathy in streptozotocin‑induced diabetic rats.
Silva VAO; André ND; Sousa TAE; Alves VM; Kettelhut IDC; De Lucca FL
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184090
[TBL] [Abstract][Full Text] [Related]
27. High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats.
Chen KB; Uchida K; Nakajima H; Yayama T; Hirai T; Rodriguez Guerrero A; Kobayashi S; Ma WY; Liu SY; Zhu P; Baba H
Spine (Phila Pa 1976); 2011 Dec; 36(25):2122-9. PubMed ID: 21343866
[TBL] [Abstract][Full Text] [Related]
28. Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice.
McVicar CM; Ward M; Colhoun LM; Guduric-Fuchs J; Bierhaus A; Fleming T; Schlotterer A; Kolibabka M; Hammes HP; Chen M; Stitt AW
Diabetologia; 2015 May; 58(5):1129-37. PubMed ID: 25687235
[TBL] [Abstract][Full Text] [Related]
29. Restoration of endogenous substance P is associated with inhibition of apoptosis of retinal cells in diabetic rats.
Yang JH; Guo Z; Zhang T; Meng XX; Xie LS
Regul Pept; 2013 Nov; 187():12-6. PubMed ID: 24045094
[TBL] [Abstract][Full Text] [Related]
30. Receptor for advanced glycation end product expression in experimental diabetic retinopathy.
Wang Y; Vom Hagen F; Pfister F; Bierhaus A; Feng Y; Gans R; Hammes HP
Ann N Y Acad Sci; 2008 Apr; 1126():42-5. PubMed ID: 18448794
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.
Zhang Y; Zhang J; Wang Q; Lei X; Chu Q; Xu GT; Ye W
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):278-85. PubMed ID: 20688733
[TBL] [Abstract][Full Text] [Related]
32. High-mobility group Box-1 is involved in NMDA-induced retinal injury the in rat retina.
Sakamoto K; Mizuta A; Fujimura K; Kurauchi Y; Mori A; Nakahara T; Ishii K
Exp Eye Res; 2015 Aug; 137():63-70. PubMed ID: 26079740
[TBL] [Abstract][Full Text] [Related]
33. The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway.
Zhu DD; Wang YZ; Zou C; She XP; Zheng Z
Biochem Biophys Res Commun; 2018 Sep; 503(2):921-929. PubMed ID: 29932924
[TBL] [Abstract][Full Text] [Related]
34. Expression of Netrin-1 in diabetic rat retina.
Zhang X; Liu J; Xiong S; Xia X; Xu H
Eye Sci; 2013 Sep; 28(3):148-52. PubMed ID: 24579557
[TBL] [Abstract][Full Text] [Related]
35. P66Shc expression in diabetic rat retina.
Zhao MH; Hu J; Li S; Wu Q; Lu P
BMC Ophthalmol; 2018 Feb; 18(1):58. PubMed ID: 29482510
[TBL] [Abstract][Full Text] [Related]
36. Cellular mechanisms of high mobility group 1 (HMGB-1) protein action in the diabetic retinopathy.
Santos AR; Dvoriantchikova G; Li Y; Mohammad G; Abu El-Asrar AM; Wen R; Ivanov D
PLoS One; 2014; 9(1):e87574. PubMed ID: 24498140
[TBL] [Abstract][Full Text] [Related]
37. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
[TBL] [Abstract][Full Text] [Related]
38. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
[TBL] [Abstract][Full Text] [Related]
39. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
[TBL] [Abstract][Full Text] [Related]
40. MiR-204 inhibits inflammation and cell apoptosis in retinopathy rats with diabetic retinopathy by regulating Bcl-2 and SIRT1 expressions.
Qi F; Jiang X; Tong T; Chang H; Li RX
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6486-6493. PubMed ID: 32633335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
